Differences in age at onset and familial aggregation between clinical types of Idiopathic Parkinson's disease

Movement Disorders

Volumn 19, Issue 9, 2004, Pages 1059-1064

  Korchounov, Alexei ^a,d   Schipper, Hayo I ^b   Preobrazhenskaya, Irina S ^c   Kessler, Kirn R ^a   Yakhno, Nikolay N ^c  

^a GOETHE UNIVERSITY   (Germany)

^b Schlossberg Clin Parkinson's Dis   (Germany)

^c I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^d Diabetes Clinic Bad Nauheim   (Germany)

Author keywords

Age at onset; Clinical types; Epidemiology; Family history; Parkinson's disease

Indexed keywords

ADULT; AGED; AKINESIA; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; SEGREGATION ANALYSIS; STANDARDIZATION; TREMOR;

AGE OF ONSET; AGED; FEMALE; HUMANS; HYPOKINESIA; MALE; MIDDLE AGED; MUSCLE RIGIDITY; PARKINSON DISEASE; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; TREMOR;

EID: 4644355475     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20061     Document Type: Article

References (51)

1. Tanner CM, Goldmann SM. Epidemiology of Parkinson's disease. Neurol Clin 1996;14:317-335.
2. Golbe LI, Farrell TM, Davis PH. Follow-up study of early-life protective and risk factors in Parkinson's disease. Mov Disord 1990;5:66-70.
3. Koller W, Vetere-Overfield B, Gray C, Alexander C, Chin T, Dolezal J, Hassanein R, Tanner C. Environmental risk factors in Parkinson's disease. Neurology 1990;40:1218-1221.
4. Semchuk KM, Love EJ, Lee RG. Parkinson's disease: a test of the multifactorial etiologic hypothesis. Neurology 1993;43:1173-1180.
5. Tanner CM, Chen B, Wang W, Peng M, Liu Z, Liang X, Kao LC, Gilley DW, Goetz CG, Schoenberg BS. Environmental factors and Parkinson's disease: a case-control study in China. Neurology 1989;39:660-664.
6. Gorell JM, Johnson CC, Rybicki BA. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 1999;20:239-247.
7. Mjones H. Pralysis agitans. A clinical genetic study. Acta Psychiatr Neurol Scand Suppl 1949;54:1-195.
8. McCann SJ, LeCouteur DG, Green AC. The epidemiology of Parkinson's disease in an Australian population. Neuroepidemiology 1998;17:310-317.
9. Payami H, Larsen K, Bernard S, Nutt J. Increased risk of Parkinson's disease in parents and siblings of patients. Ann Neurol 1994;36:659-661.
10. Bonifati V, Fabrizio E, Vanacore N, De Mari M, Meco G. Familial Parkinson's disease: a clinical genetic analysis. Can J Neurol Sci 1995;22:272-279.
11. Vieregge P, Heberlein I. Increased risk of Parkinson's disease in relatives of patients. Ann Neurol 1995;37:685.
12. De Michele G, Filla A, Volpe G, Gogliettino A, Ambrosio G, Campanella G. Etiology of Parkinson's disease. The role of environment and heredity. Adv Neurol 1996;69:19-24.
13. Marder K, Tang MX, Mejia H, Alfaro B, Cote L, Louis E, Groves J, Mayeux R. Risk of Parkinson's disease among first-degree relatives: a community-based study. Neurology 1996;47:155-160.
14. Uitti RJ, Shinotoh H, Hayward M, Schulzer M, Mak E, Calne DB. Familial Parkinson's disease - a case-control study of families. Can J Neurol Sci 1997;24:127-132.
15. Taylor CA, Saint-Hilaire MH, Cupples LA. Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study. Am J Med Genet 1999;88:742-749.
16. Zorzon M, Capus L, Pellegrino A, Cazzato G, Zivadinov R. Familial and environmental risk factors in Parkinson's disease: a case-control study in north-east Italy. Acta Neurol Scand 2002; 105:77-82.
17. Barbeau A, Roy M. Familial subsets in idiopathic Parkinson's disease. Can J Neurol Sci 1984;11(Suppl.):144-150.
18. Maraganore DM, Harding AE, Marsden CD. A clinical and genetic study of familial Parkinson's disease. Mov Disord 1991;6:205-211.
19. Rybicki BA, Johnson CC, Peterson EL, Kortsha GX, Gorell JM. A family history of Parkinson's disease and its effect on other PD risk factors. Neuroepidemiology 1999;18:270-278.
20. Polymeropoulos MH, Lavedan C, Leroy E. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
21. Leroy E, Boyer R, Auburger G. The ubiquitin pathway in Parkinson's disease. Nature 1998;395:451-452.
22. Gasser T, Muller-Myhsok B, Wszolek ZK. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 1998;18:262-265.
23. Farrer M, Gwinn-Hardy K, Muenter M. A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. Hum Mol Genet 1999;8:81-85.
24. Kitada T, Asakawa S, Hattori N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392:605-608.
25. Foltynie T, Sawcer S, Brayne C, Barker RA. The genetic basis of Parkinson's disease. J Neurol Neurosurg Psychiatry 2002;73:363-370.
26. Gasser T. Genetics of Parkinson's disease. J Neurol 2001;248:833-840.
27. Riess O, Kruger R, Schulz JB. Spectrum of phenotypes and genotypes in Parkinson's disease. J Neurol 2002;249(Suppl.):15-20.
28. Benecke R. Clinical features and laboratory findings for differentiating parkinsonian syndromes. J Neurol 2002;249(Suppl.):6-14.
29. Oertel WH, Quinn NP. Parkinsonism. In: Brandt T, Caplan LR, Dichgans J, Diener HC, Kennard C, editors. Neurological disorders: course and treatment. San Diego: Academic Press; 1995. p 715-772.
30. Moilanen JS, Autere JM, Myllyla VV, Majamaa K. Complex segregation analysis of Parkinson's disease in the Finnish population. Hum Genet 2001;108:184-189.
31. Gibb WRG, Fearnley JM, Lees AJ. The anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability. Adv Neurol 1990;53:31-40.
32. Ward CD, Gibb WRG. Research diagnostic criteria for Parkinson's disease. Adv Neurol 1990;53:245-249.
33. Zareparsi S, Tyalor TD, Harris EL, Payami H. Segregation analysis of Parkinson's disease. Am J Med Genet 1998;80:410-417.
34. Maher NE, Currie LJ, Lazzarini AM, Wilk JB, Taylor CA, Saint-Hilaire MH, Feldman RG, Golbe LI, Wooten GF, Myers RH. Segregation analysis of Parkinson's disease revealing evidence for a major causative gene. Am J Med Genet 2002;109:109-197.
35. Tanner CM, Hubble JP, Chen P. Epidemiology and genetics of Parkinson's disease. In: Watts RL, Koller W, editors. Movement disorders: neurological principles, and practice. New York: McGraw-Hill; 1999. p 137-152.
36. Marttila RJ, Rinne UK. Epidemiology of Parkinson's disease in Finland. Acta Neurol Scand 1976;53:81-102.
37. Mutch WJ, Dingwall-Fordyce I, Downie AW, et al. Parkinson's disease in a Scottish city. Br Med J 1986;292:534-536.
38. Rosati G, Granieri E, Pinna L, et al. The risk of Parkinson's disease in Mediterranean people. Neurology 1980;30:250-255.
39. Okada K, Kobayashi S, Tsunematsu T. Prevalence of Parkinson's disease in Izumo City, Japan. Gerontology 1990;36:340-344.
40. Reider CR, Halter CA, Castelluccio PF, Oakes D, et al. Reliability of reported age at onset of Parkinson's disease. Mov Disord 2003;18:275-279.
41. Martin WE, Young WI, Anderson VE. Parkinson's disease: a genetic study. Brain 1973;96:495-506.
42. Hirsch EC, Mouatt A, Faucheux B, Bonnet AM, Javoy AF, Graybiel AM, Agid Y. Dopamine, tremor and Parkinson's disease. Lancet 1992;340:125-126.
43. Jellinger KA. Post-mortem studies in Parkinson's disease - is it possible to detect brain areas for specific symptoms? J Neural Transm Suppl 1999;56:1-26.
44. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological and neurochemical correlations. J Neurol Sci 1973;20:415-455.
45. Vingerhoets FJ, Schulzer M, Calne DB, Snow BJ. Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion? Ann Neurol 1997;41:58-64.
46. Antonini A, Moeller JR, Nakamura T, Spetsieris P, Dhawan V, Eidelberg D. The metabolic anatomy of tremor in Parkinson's disease. Neurology 1998;51:803-810.
47. Rajput AH, Pahwa R, Pahwa P, Rajput A. Prognostic significance of the onset mode in parkinsonism. Neurology 1993;46:829-830.
48. Elbaz A, McDonnell SK, Maraganore DM, et al. Validity of family history data on PD. Evidence for a family information bias. Neurology 2003;61:11-17.
49. Levy G, Tang MX, Cote LJ, et al. Motor impairment in PD: relationship to incident dementia and age. Neurology 2000;55: 539-544.
50. Jankovic J, Kapadia AS. Functional decline in Parkinson's disease. Arch Neurol 2001;58:1611-1615.
51. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, et al. Variable expression of Parkinson's disease: a baseline analysis of the DATATOP cohort. Neurology 1990;40:1529-1534.